Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids In Cardiac Surgery Trial
2010-023093-39Phase 3Completed
- Sponsor
- Policlinico di Bari
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cardiac disease and Myocardial injury comparing Methylprednisolone arm with Placebo / standard care arm (2 arms). Primary endpoints: 30-day all-cause mortality and Composite of 30-day all-cause mortality or significant myocardial injury. Started Apr 2011; status: completed.
02
Drugs
methylprednisolone
03
Conditions
cardiac diseaseMyocardial injury
Beyond the preview
Go deeper on 2010-023093-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023093-39.